The presence of elevated circulating triacylglycerol (TG)-rich very low density lipoprotein (VLDL) and apolipoprotein B-100 (apoB-100) levels represents an independent risk factor for coronary artery disease. Triacylglycerol hydrolase catalyzes the mobilization of cytoplasmic TG stores. To test the hypothesis that the enzyme plays a role in the provision of core lipids for the assembly of VLDL, we inhibited the lipase activity in primary rat hepatocytes and analyzed lipid and apoB synthesis and secretion. Inhibition of lipolysis resulted in a dramatic decrease in secretion of TGs. In addition, secretion of cholesteryl ester and phosphatidylcholine was substantially decreased. Analysis of secreted apolipoproteins indicated that apoB-100 secretion was much more sensitive to lipase inhibition than was apoB-48 secretion, perhaps because of the ability of apoB-48 to be secreted as a relatively lipid-poor particle. The results agreed with those obtained with hepatoma cells transfected with triacylglycerol hydrolase cDNA, in which preferential lipidation of apoB-100 was observed. Together, our findings provide evidence that inhibition of intracellular TG hydrolysis significantly decreases apoB-100 secretion and suggest that triacylglycerol hydrolase may be a suitable pharmacological target in efforts to lower plasma lipid levels.
from lipolysis of stored TG followed by re-esterification (1) (2) (3) (4) . HepG2 cells, a cell line derived from a human hepatoma, are unusual in that they secrete few VLDL-size particles but do secrete apoB in the density range of low-density lipoprotein and high-density lipoprotein (5, 6) . Gibbons et al. (5) suggested that the impaired secretion of VLDL in HepG2 cells is due to a defect in the mobilization of TG from cytosolic pools. This conclusion was supported by studies by Wu et al. (7) who demonstrated a similar inability of TG to be mobilized from HepG2 cells. They also showed that exogenous oleate entered a "secretion-coupled" pool in the microsomes that stimulated apoB secretion with newly made TG. When the oleate was withdrawn from the medium, the stored TG was not available for secretion.
Until recently, enzymes involved in the hydrolysis of stored TG have not been described, with the exception of hormone-sensitive lipase (HSL) (8) . This lipase was first characterized in adipose tissue and is activated by a cAMP cascade when energy supply is low. HSL is not found in appreciable quantities in the liver. In addition, fatty acids released by the cytosolic HSL in HepG2 cells overexpressing the enzyme were diverted into the oxidative pathway rather than into the secretory pathway, which suggests that subcellular localization of the lipase may be important in the channeling of substrates (9) . We have reported the purification of a liver triacylglycerol hydrolase (TGH) and hypothesized that the lipase may be involved in the mobilization of stored TG for VLDL assembly (10) . TGH was localized to the endoplasmic reticulum (ER) and was also found to associate with lipid droplets (11) . In addition, the enzyme was absent from liver-derived cell lines (HepG2 and McArdle RH7777) with inadequate mobilization of stored lipid for VLDL assembly (11) . Transfection of McArdle RH7777 cells with rat TGH cDNA resulted in increased mobilization of intracellular TG and lipidation of apoB-100 (12) .
The objective of the present research was to explore the relationship between TGH and the provision of lipid for VLDL (apoB) secretion. A direct relationship between elevated levels of plasma apoB and increased risk of developing atherosclerosis is well established. The metabolic syndrome of insulin resistance, hypertension, and visceral obesity is also characterized by elevated plasma concentration of TG-rich lipoproteins (reviewed in refs 13, 14) . Hypertriglyceridemia caused by increased plasma concentrations of apoB is the most consistent lipid disorder in the metabolic syndrome as well as a risk factor for cardiovascular disease (reviewed in refs 13, 15) . Although the precise regulation of apoB metabolism has not been fully elucidated, the underlying mechanism may relate to oversecretion or impaired clearance of TGrich lipoproteins, or both.
We report here that inhibition of lipolysis by a lipase inhibitor, diethyl-p-nitrophenyl phosphate (E600), and by a specific TGH inhibitor, 4,4,4-trifluoro-2-[2-(3-methylphenyl)hydrazono]-1-(2-thienyl)butane-1,3-dione (GR148672X), in intact cells resulted in decreased mobilization of stored TG and a dramatic decrease of apoB-100 secretion. These studies should provide the basis for development of selective treatments that decrease the amount of VLDL secreted from the liver and, as a consequence, decrease the risk of cardiovascular disease and stroke related to atherosclerosis.
MATERIALS AND METHODS

Materials
Oleic acid (OA), triolein, essentially fatty acid-free bovine serum albumin (BSA), p-nitrophenyl fatty acyl esters, protein A-Sepharose CL-4B, diethyl-p-nitrophenyl phosphate (E600), fumed silica (Cab-O-Sil), Sigma Diagnostics Infinity Triglyceride Reagent, anti-sheep IgG-horseradish peroxidase conjugate, NADH (reduced form of nicotinamide adenine dinucleotide), and tertbutyl hydroperoxide were purchased from Sigma Chemical (St. Louis, MO 
Subcellular fractionations
Microsomes from male Sprague-Dawley rats each weighing 225-250 g were prepared essentially as described previously (11) . Briefly, rats were exsanguinated via the abdominal aorta, and livers were removed and washed with ice-cold Tris-buffered saline. Twenty percent liver homogenates (w/v) were obtained by using a Waring blender for 30 s at low speed in 250 mM sucrose, 50 mM Tris-HCl, pH 7.4, and 5 mM EDTA. Unbroken cells and cellular debris were removed by centrifugation at 500g for 10 min. Crude mitochondrial pellets were obtained by centrifugation of the 500g supernatant at 15,000g for 10 min, and microsomal membranes were prepared by centrifugation of 15,000g supernatant at 106,000g for 1 h. Microsomes from McArdle RH7777 cells were prepared similarly except that sonication was used for cell disruption (11, 12) .
Purification of rat liver TGH
Rat liver TGH was purified from detergent-solubilized microsomes by a procedure described previously for the purification of TGH from porcine liver (10) . The identity of TGH was confirmed by N-terminal protein sequencing.
Cell culture
Hepatocytes were isolated by collagenase perfusion of the livers from male Sprague-Dawley rats (body weight 125-150 g) that had been fed ad libitum. The cells were cultured in DMEM containing 15% FBS (16) . HepG2 cells were cultured in MEM containing 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, penicillin (100 U/ml), streptomycin (100 µg/ml), and 10% FBS (11) . McArdle RH7777 cells were cultured in DMEM containing pyruvate, antibiotics, 10% FBS, and 10% horse serum. All cultures were maintained in 60-or 100-mm dishes (Corning, Nepean, Ontario, Canada) at 37°C in humidified air (89-91% saturation) containing 5% CO 2 .
Lipase assay
Lipolytic activities in microsomal membranes prepared from rat liver and in microsomal membranes from stably mock-transfected (empty vector) and rat TGH cDNA-transfected McArdle RH7777 cells were assessed by using the chromogenic substrates p-nitrophenyl laurate and palmitate (10) .
Inhibition of TGH
Purified rat TGH or microsomes were preincubated for 30 min in the presence or absence of 100 µM E600 or 10 µM GR148672X on ice before addition of the lipase substrate. The effectiveness of the inhibitor in intact cells was assessed by incubation for 2 h in DMEM with or without the inhibitors. The cells were washed, microsomes were prepared, and microsomal lipase activity was determined.
Secretion of lipid stores from hepatoma cells
McArdle RH7777 cells (cytomegalovirus [CMV] vector-only and TGH-transfected cells) (12) and HepG2 cells at 70% confluency in 60-mm dishes were incubated for 12 h with 2 ml of OA complexed to BSA at 0.4 mM OA-0.5% BSA in DMEM and [ 3 H]glycerol at 10 µCi/dish. Cells were washed and incubated for 2 h with 100 µM E600 or with dimethyl sulfoxide (DMSO) (control cells). The final concentration of DMSO was 0.1%. Cells were then incubated for 6 h in 2 ml of DMEM with or without E600 (100 µM). Media were collected and centrifuged, and 1 ml was used for lipid analysis (see below). Cells were washed with ice-cold PBS, harvested in 2 ml of PBS, sonicated, and analyzed for protein content. The lipids were then analyzed as described below.
Turnover and secretion of lipids in primary rat hepatocytes
Hepatocytes plated on collagen-coated 60-mm dishes at 2.5 × 10 6 cells/dish were incubated for 6 h in DMEM containing 15% FBS. Cells were then washed with DMEM and incubated for 12 h in DMEM without FBS. Cells were then incubated for 4 h in 2 ml of DMEM containing 0.4 mM [ 3 H]OA (21,000 dpm/nmol) complexed to 0.5% fatty acid-free BSA and 1.5 × 10 6 dpm/dish [ 14 C]glycerol in the presence or absence of E600 (100 µM) or GR148672X (10 µM). After the incubation, some cells and media were collected for analysis (pulse). Remaining dishes that were incubated in the absence of an inhibitor were washed with DMEM and incubated for 1 h with DMEM to allow secretion of lipoproteins containing de novo synthesized lipids. Cells were then incubated with DMEM with or without E600 (100 µM) or GR148672X (10 µM) for 1 h, a time determined to be sufficient for the inhibitor to enter the cell and inhibit microsomal TGH. The media were discarded and were replaced with fresh media ± E600 (100 µM) or GR148672X (10 µM), and incubation proceeded for 4 h. Finally, cells and media were collected for analysis (chase).
Cellular and secreted TG mass was determined enzymatically with Sigma Diagnostic Infinity TG Reagent. Briefly, lipids from cells and media after the chase period were extracted with chloroform/methanol (2:1, v/v), dried under nitrogen, and resuspended in 20 µl of ethanol. TG reagent (1 ml) was added, and TG content was analyzed according to instructions from the manufacturer, with trioleoylglycerol as standard.
Lipid analysis
Lipids were extracted from samples with chloroform/methanol (2:1, v/v) in the presence of nonradioactive lipid carriers (phosphatidylcholine [PC] , OA, trioleoylglycerol, and cholesteryl oleate) (12) . The chloroform phase containing lipids was dried under nitrogen, redissolved in a small volume of chloroform, and applied to silica gel H thin-layer chromatography plates. The plates were developed to one-third the height with chloroform/methanol/acetic acid/water (25:15:4:2, by vol) to allow separation of PC from other polar glycerolipids, followed by development in heptane/isopropyl ether/acetic acid (60:40:4, by vol) to separate neutral lipids (fatty acids, TG, and cholesteryl esters [CEs]) (12) . The lipid classes were visualized by exposure to iodine vapor, the bands were scraped, and the associated radioactivity was determined by scintillation counting.
Secretion of apoB by primary rat hepatocytes
Primary rat hepatocytes in 60-mm dishes were washed and incubated 4 h with DMEM containing 0.4 mM OA plus 0.5% BSA. Cells were then washed and incubated for 2 h with 2 ml of DMEM with or without E600 (100 µM) or GR148672X (10 µM), followed by a wash with DMEM without leucine ± E600 (100 µM) or GR148672X (10 µM) ± lactacystin (10 µM). Cells were incubated for 2 h in 2 ml of leucine-deficient DMEM supplemented with 250 µCi [ 3 H]leucine in the presence or absence of lactacystin, E600 (100 µM), or GR148672X (10 µM). Media were removed and briefly centrifuged to remove cellular debris. Cells were collected in immunoprecipitation buffer (12) containing 1 mM benzamidine and were homogenized by sonication, and protein concentration was determined. Immunoprecipitation and analysis of apoB were performed as described previously (12) . Briefly, to 1 ml of cell sonicates and culture media (adjusted with 10X immunoprecipitation buffer and containing 1 mM final concentration of benzamidine) anti-human apoB IgG (10 µl) was added. The mixture was incubated on a rotating rack for 12 h at 4°C, after which 50 µl of protein A-Sepharose was added and the mixture was incubated for 3 h. The beads were pelleted by brief centrifugation and were washed three times with excess immunoprecipitation buffer; then 0.1 µg of rat VLDL protein was added, followed by denaturing electrophoresis sample buffer. Samples were boiled and underwent electrophoresis in 5% polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS). Gels were silver stained, and bands corresponding to apoB-48 and apoB-100 were excised and dissolved at 60°C in 0.2 ml of 60% perchloric acid followed by 0.4 ml of 30% hydrogen peroxide. Radioactivity associated with apoB-48 and apoB-100 was determined by using the Hionic-Fluor scintillation cocktail (Packard Instrument, Meriden, CT) and scintillation counting.
The mass of apoB in media after a 4-h chase was also analyzed. Fumed silica (Cab-O-Sil) was added to the media (3 mg of silica/ml of medium), and the mixture was incubated for 45 min at 4°C (17) . The apoB bound to silica was collected by brief centrifugation (1 min at 2600g); the pellet was washed, resuspended in denaturing electrophoresis sample buffer, and boiled; and proteins were resolved on SDS-polyacrylamide (5%) gels. Proteins were transferred to a nitrocellulose membrane and probed with anti-human apoB IgG (1:5000 dilution) followed by a secondary antibody (donkey anti-sheep IgG-horseradish peroxidase, 1:5000 dilution). Reactivity was detected by enhanced chemiluminescence, and the relative intensities of the resulting bands on the blot were analyzed by densitometry using Bio-Rad Quantity One software (Bio-Rad, Mississauga, Ontario, Canada).
Pulse-chase analysis of apoB synthesis in primary rat hepatocytes
Primary rat hepatocytes in 60-mm dishes were washed and incubated overnight with DMEM containing 15% FBS and 0.4 mM OA plus 0.5% BSA. Cells were then washed and incubated for 1 h with 2 ml of methionine-and cysteine-free DMEM with or without E600 (100 µM) or GR148672X (10 µM). Cells were then incubated in methionine-and cysteine-free DMEM with or without E600 (100 µM) or GR148672X (10 µM) containing 50 µCi/ml 35 S-labeled methionine and cysteine for 15 min. Cells were washed and chased with 2 ml of DMEM (with methionine and cysteine) ± lipase inhibitors for 30 min. Media were collected and cleared of cellular debris by centrifuging at 2600g for 2 min. Cells were scraped into 2 ml of immunoprecipitation buffer containing a protease inhibitor cocktail (Roche Diagnostics) and were briefly sonicated. Aliquots (1 ml) of media and sonicates were precleared via a 3-h incubation at 4°C with 20 µl of protein A-Sepharose beads. The beads were pelleted by centrifugation for 2 min at 1000g. Immunoprecipitations of apoB from the supernatants, SDS-polyacrylamide gel electrophoresis (PAGE), and transfers to nitrocellulose membranes were performed as described above. Quantitation of apoB was determined by using a PhosphorImager. Resulting bands were quantified as above.
Lactate dehydrogenase (LDH) assay
Primary rat hepatocytes in 60-mm dishes were washed and incubated overnight with DMEM containing 15% FBS and 0.4 mM OA-0.5% BSA. Cells were then washed and incubated for 1 h with 2 ml of DMEM with or without E600 (100 µM) or GR148672X (10 µM). Media were removed, and cells were reintroduced into 2 ml of DMEM with or without E600 or GR148672X and incubated for 4 h. Some cells were incubated for 1 h with 2 ml of DMEM containing 400 µM tert-butyl hydroperoxide. This treatment results in disruption of cell integrity and release of the cytosolic LDH into the medium. Samples of medium were collected after treatments and cleared of cellular debris by centrifuging at 2600g for 2 min. Cells were scraped into 1 ml of PBS containing a protease inhibitor cocktail (Roche Diagnostics) and were briefly sonicated. LDH activity in cells and media was determined as described previously (18, 19) . Assays were conducted in triplicate with 15 µl of culture medium or 7.5 µl of cell sonicates supplemented with 7.5 µl of PBS. The assay was started by addition of 250 µl of substrate solution containing 100 mM phosphate buffer, pH 7.4, 1.4 mM sodium pyruvate, and 0.2 mM NADH. Absorbance at 340 nm was then monitored every minute for 10 min. LDH activity is expressed as the percentage of media LDH activity relative to total (cells plus media) activity after 3 min of reaction time.
Other methods
The 7.5 mM OA-10% BSA stock solution was prepared by dissolving 5g fatty acid-free BSA in 50 ml DMEM (12) . The solution was heated to 56°C, added to 0.106 g of OA, stirred until the solution clarified, and sterilized by filtration. Protein concentration was determined by the BioRad Protein Assay kit by using BSA as a standard. Statistical analysis was performed by using Student's t test.
RESULTS
Inhibition of microsomal lipase activity
Like porcine hepatic microsomes (10), rat hepatic microsomes contain about 70% of total hepatic alkaline lipase activity, with the majority of the microsomal lipase activity copurifying with TGH. Figure 1 shows the inhibition of lipolytic activity by E600 in rat hepatic microsomes and of purified TGH. E600 (100 µM) inhibited more than 90% of the lipase activity in microsomes and more than 95% of the activity using the purified enzyme.
Inhibition of TGH activity in intact cells by E600
The rat hepatoma cell line McArdle RH7777 does not express TGH (11, 12) , so cell lines stably transfected either with pBK-CMV or with pBK-CMV containing the rat TGH cDNA were generated (12) . Incubation of McArdle RH7777 cells with E600 followed by analysis of remaining microsomal lipolytic activity indicated that E600 entered the cells and the ER, where TGH resides, and inhibited TGH activity (Fig. 2) . The inhibitor had little effect on endogenous lipolytic activity present in McArdle RH7777 cell microsomes.
E600 did not affect glycerolipid secretion from wild-type McArdle RH7777 and HepG2 cells but did inhibit TGH-dependent lipid secretion
McArdle RH7777 cells expressing TGH have demonstrated increased mobilization and secretion of stored cellular TG (12) . Wild-type McArdle RH7777 and HepG2 cells appear to have inadequate mobilization of stored TG for lipoprotein assembly and secretion (5, 7, 12) . Figure 3A shows that the TGH-dependent secretion of stored TG was inhibited by E600. As expected, very little or no effect on secretion of preformed TG was seen in mock-transfected McArdle RH7777 cells or in HepG2 cells. The inhibitory effect appeared to be TG specific, because phospholipid secretion was not significantly affected by the inhibitor treatment (Fig. 3B) .
Mobilization of lipids in primary rat hepatocytes
To further assess the function of TGH and its role in the mobilization of stored cellular TGs for VLDL assembly, inhibition studies were carried out with primary rat hepatocytes in which the role of the lipolysis/re-esterification pathway in VLDL formation has been established (1-4). We followed cellular lipid synthesis, turnover, and secretion from the point of the acyl acceptor (glycerol backbone of glycerolipids) and acyl donor (fatty acid) by incubating the cells with 14 Clabeled glycerol and 3 H-labeled OA (Figs. 4 and 5 ). After prelabeling of cellular lipids, cells were incubated for 1 h to allow secretion of lipoproteins containing de novo synthesized lipids (wash period) followed by another 1-h incubation in the presence or absence of E600 (inhibition period). The cells were then incubated for 4 h in the presence or absence of E600 (chase period). During the chase period, 57% of cellular glycerol-labeled TG was turned over in the absence of the inhibitor (P<0.009) compared with only 19% turnover (not significant) in the presence of the inhibitor (Fig. 4A) . PC turnover was not affected by E600 (Fig. 4B) . Secretion of stored glycerollabeled TG was decreased by 41% (P<0.015) in the presence of E600 (Fig. 5A ). This result is further evidence that lipolysis is an important step for secretion of stored TG. Primary hepatocytes can secrete relatively constant levels of TG after removal of oleate from culture media (see below) (12) . However, only 18-20% of TG labeled in the glycerol backbone was secreted (Fig. 5A ), which indicates a dilution of the [ 14 C]glycerol released by lipolysis with unlabeled glycerol before re-esterification. This observation agrees with previous results (1).
Very little (if any) de novo fatty acid synthesis occurs in primary rat hepatocytes during 4 h of culture in the presence of exogenous fatty acid because of the inhibition of acetyl-CoA carboxylase (20) . Under these conditions, the contribution of de novo lipogenesis to VLDL TG is minimal, and the exogenous fatty acid is the primary contributor to TG synthesis. Hence, the specific radioactivity of exogenous oleate correlates strongly with intracellular TG mass. Using radiolabeled OA as the tracer also allows for the investigation of CE metabolism. During the pulse period, the incorporation of exogenous fatty acid (21,000 dpm/nmol) into lipids was as follows: 94 nmol into TG (Fig. 4C, pulse) , 5 nmol into PC (Fig. 4D, pulse) , and 1 nmol into CE (Fig. 4E, pulse) . When E600 was introduced during the pulse labeling, it had no effect on incorporation of fatty acid into PC or TG but significantly decreased incorporation of fatty acid into CE (34% decrease, P<0.04). It is unlikely that E600 inhibited acyl-CoA:cholesterol acyltransferase (ACAT) activity because another esterase inhibitor from the same series, bis(4-nitrophenyl)phosphate, at concentrations used in our experiments had no effect on ACAT activity in vitro (21) . Rather, the lower incorporation of fatty acid into CE in the presence of the inhibitor may be related to the inhibition of TG turnover, i.e., the released fatty acid from TG may serve as a substrate for ACAT. This view is supported by the observation that the levels of labeled intracellular CE more than doubles (from 1 nmol to 2.35 nmol) during the chase period (Fig. 4E) , when the only source of labeled fatty acid is the prelabeled pool of lipids (such as TG and phospholipids). Interestingly, the increased cellular levels of labeled CE during the chase period did not lead to increased CE secretion (Fig. 5C ). Although relatively constant levels (about 5 nmol) of oleate-labeled TG secretion were observed during both pulse and chase periods (Fig. 5B) , this was not the case for CE or PC. A significantly larger proportion (about 160 pmol) of oleate-labeled CE was secreted in the presence of the extracellular fatty acid compared with the chase period (about 80 pmol), and this was despite the apparent increase of oleate-labeled CE levels during the chase period. The data suggest dissimilar pathways for the assembly of the two neutral lipids into VLDL. Levels of secretion of prelabeled PC were also lower than those obtained in the presence of exogenous oleate (Fig. 5D) . The relatively constant secretion of oleate-labeled TG (Fig. 5B ) confirms earlier observations of the preferred utilization of fatty acids incorporated into the TG storage pool for assembly into VLDL TG (1). Inhibition of the mobilization of preformed TG by E600 dramatically decreased TG secretion (Fig. 5B) , which again demonstrated the important role of lipolysis in the assembly and secretion of VLDL.
The decrease in TG secretion after treatment of hepatocytes with the lipase inhibitor was confirmed by measurements of the TG mass in the media and within the cells. The data presented in Fig. 6 agree well with those obtained by metabolic radiolabeling. Although about 15% of stored TG was secreted during the 4-h chase in control incubations, less than 5% of stored TG was secreted in the presence of E600.
Inhibition of TGH resulted in decreased apoB secretion
Because E600 treatment decreased secretion of lipids that are the usual components in apoBcontaining lipoproteins (PC, TG, CE), the effect of E600 on secretion of apoB was examined. Rat hepatocytes produce two forms of apoB: apoB-48, corresponding to the N-terminal 48% of the total apoB polypeptide, and apoB-100, corresponding to the entire apoB molecule. Preincubation of hepatocytes with E600 resulted in decreased secretion of both [ 3 H]leucinelabeled apoB-48 (40%, P<0.02) and apoB-100 (90%, P<0.0001) (Fig. 7A) . The reasons for differences between the observed inhibition of apoB-48 vs. apoB-100 secretion after E600 treatment are not known but may be related to the fact that apoB-48 can be secreted as a relatively lipid-poor particle (high density), whereas lipid-poor apoB-100 is thought to be secretion incompetent and undergoes intracellular degradation (22) (23) (24) (25) . The data support our previous observations for McArdle RH7777 cells transfected with TGH cDNA, when we found preferential lipidation of apoB-100 (i.e., increased apoB-100 VLDL formation) (12) . Analysis of cellular [ 3 H]apoB levels indicated that the inhibitor treatment decreased apoB-48 levels by 30% (P<0.05) and apoB-100 levels by 80% (P<0.0001) (Fig. 7B) . Intracellular degradation of apoB in hepatoma cell lines has been postulated to be mediated primarily by the proteasome; however, inclusion of a proteasome inhibitor, lactacystin, during incubations did not significantly increase cellular or secreted apoB levels (Fig. 7) . This result suggests that the proteasome may not be the major pathway of apoB degradation in primary rat hepatocytes. Our results support recent data showing that in primary rat hepatocytes a degradation process within a post-ER compartment rather than in the ER is involved in the loss of apoB-100 from the Golgi apparatus after treatment of the cells with polyunsaturated fatty acids (26) . We confirmed our metabolic labeling studies by analysis of secreted apoB by use of immunoblotting. Secretion of apoB-100 from inhibitor-treated cells was substantially decreased (70%), whereas apoB-48 secretion was more resistant to the inhibitor (30% decrease) (Fig. 8 ).
It could be argued that E600 may not be a specific TGH inhibitor because it also inhibits other lipases (27) . To address this issue directly, we performed studies with a specific TGH inhibitor GR148672X that has been shown not to inhibit the activities of pancreatic lipase, HSL, lipoprotein lipase, and acetylcholine esterase (C. Borg-Capra et al., personal communication). Under the same conditions as those described for E600 in Figs. 6 and 8, except using 10 µM GR148672X instead of 100 µM E600, 14% of stored TG was secreted in control incubations. This proportion decreased to 7.5% in the presence of the specific inhibitor (Fig. 9A) , a decrease of 46% (P<0.02). Secretion of apoB-100 was decreased by 42% (P<0.03) and that of apoB-48, by 20% (P<0.06) (Fig. 9B) .
To demonstrate that treatment of primary rat hepatocytes with E600 or GR148672X did not reduce synthesis of apoB, we performed metabolic labeling (pulse-chase) experiments with 35 Slabeled methionine and cysteine as described by Jiang et al. (28) .The results in Fig. 10A demonstrate that neither of these lipase inhibitors affected the synthesis of nascent apoB-48 or apoB-100. Media apoB levels were nearly undetectable during these pulse-chase experiments, an expected result given the time course of the assembly and secretion of a lipoprotein particle (about 45 min) (29) . The inhibitors did not affect the general secretory pathway as assessed by the secretion of albumin (Fig. 10B ) and were not detrimental to cell viability as assessed by the leakage of LDH from cells into the media (Fig. 10C) .
DISCUSSION
TG secreted in VLDL particles from the liver is a powerful source of energy for muscle or other tissues. The fatty acids that make up VLDL TG are mainly derived from a preformed TG storage pool; only some of the fatty acid is derived from de novo synthesis (1) (2) (3) (4) . Studies (30) have demonstrated that even during induced de novo lipogenesis by carbohydrate feeding, the secretion of preformed fatty acids accounted for 99% of total VLDL TG secretion before the start of the dietary regimen, and 70% and 79% after 1 day and 4 days of lipogeneic diet, respectively. The possible sources of the stored hepatic TG fatty acids are de novo synthesized fatty acids, plasma fatty acids derived from adipose tissue TG hydrolysis, TG from remnant particles that are endocytosed, or fatty acids from turnover of hepatic membrane lipids. The importance of adipose tissue-derived fatty acids for production of hepatic TG stores that would be used for VLDL assembly was recently demonstrated by studies with mice in which the gene coding for HSL was ablated (31) . HSL deficiency resulted in decreased fatty acid delivery to the liver, lower intracellular liver TG concentration, and decreased VLDL TG secretion (31) . Hepatic TGH protein levels in HSL null mice are not changed (unpublished results), which suggests that mobilization of hepatic TG stores in these mice may not be affected and the decreased VLDL production would thus be directly correlated to the amount of intrahepatic TG stores. It has been demonstrated that the majority of exogenously derived fatty acids are not used directly for the synthesis of VLDL TG but must first enter the TG storage pool before being mobilized by lipolysis and re-esterification (32).
Microsomal membranes harbor the majority of neutral TG lipase activity in liver (10) . Only about 10% of hepatic TG lipase activity was detected in the soluble cytosolic fraction (10) . On purification of the lipolytic activity from hepatic microsomes, most of the activity copurified with TGH. TGH was subsequently localized to various subfractions of the ER (11). Another candidate protein, arylacetamide deacetylase (AADA), was found to share homology with HSL and was reported to be present in the microsomes of human liver and ileum (33) . This enzyme has been demonstrated to activate carcinogenic esters such as arylamine derivatives. Lipolytic activity of AADA was not tested, but expression of the AADA cDNA in HepG2 cells increased secretion of free fatty acids and TG (4). Murine AADA tissue distribution and diurnal regulation of Aada gene expression were also described (34) . Clearly, further studies are required to establish the role of AADA in hepatic glycerolipid metabolism.
Our results show that a specific inhibitor of TGH decreases secretion of VLDL (TG and apoB). The majority of TGs in hepatocytes are found in cytosolic storage pools. We propose a model for the role of TGH in the liver in which the TGH substrate pool exists in lipid droplets found in the ER lumen (Fig. 11) . The TGH substrate may be derived from cytosolic stores via a process that involves microsomal triglyceride transfer protein (MTP). MTP has been shown to be required for secretion of TG-rich apoB-containing lipoproteins. MTP is necessary for proper folding of apoB (reviewed in refs 35, 36) . From studies with mice in which the MTP gene was disrupted (37), and through MTP inhibition studies (38, 39) , it became apparent that MTP function may be required for the formation of a luminal TG storage droplet. The luminal droplet may be the primary source of VLDL TG. It has been hypothesized that the luminal droplet may "fuse" with the nascent, TG-poor primordial apoB particle to form fully lipidated VLDL, but no data exist that would directly support the occurrence of such a fusion. In our model, lipolysis of the luminal droplet by TGH to partial acylglycerols and fatty acids would provide substrates for TG resynthesis by luminally localized acyltransferases followed by TG loading onto nascent apoBcontaining particles. TG that is not assembled into apoB may be returned to either cytosolic or luminal storage pools (futile cycle). There is experimental evidence for the existence of a latent (luminal) diacylglycerol acyltransferase activity (40) and luminal TG synthesis (41) . Two separate genes coding for diacylglycerol acyltransferese activity have been characterized (42, 43) . Alternatively, TGH may access TG at the inner ER membrane, as TGH has been shown to adsorb to lipid monolayers and contains a "lipid binding domain" (10) . On contact with the ER, TGs could move from the cytosolic lipid droplet into the ER bilayer. Bilayers can incorporate up to 5 mol% TG without affecting membrane integrity. However, it is difficult to conceptualize that TG already within the bilayer would need to be hydrolyzed and re-esterified to be assembled into a nascent apoB particle.
Another putative function of TGH would be delipidation of secretion-incompetent or misfolded apoB particles, which would facilitate their degradation. The idea behind this hypothesis is that misfolded apoB particles could interfere with production of correctly assembled lipoproteins by sequestering chaperones including MTP. However, TGH inhibitor treatment did not result in increased cellular apoB levels, or in alterations in the synthesis of apoB. This finding indicates that inhibition of TGH results in poorly lipidated apoB-containing particles that are subject to degradation via a regulated cellular mechanism. In addition, our recent studies suggest that apoB-associated TG is not a substrate for TGH (unpublished data). Furthermore, inhibition of TGH did not affect the secretion of albumin (Fig. 10B) , which indicates that our results were not due to a general effect of the compounds on protein translation or on the secretory pathway.
In conclusion, the observation of a marked decrease in apoB and TG secretion by inhibition of microsomal lipolytic activity provides further support for the concept that the lipolysis/reesterification pathway represents another regulated step in VLDL assembly. The lipase may therefore be an attractive target for pharmacological intervention that would reduce levels of circulating atherogenic lipoproteins. (CMV) or rat-liver TGH cDNA (TGH) were incubated for 4 h with or without E600 (100 µM). Cells were then harvested and disrupted by brief sonication, microsomes were isolated, and lipolytic activity was determined by using p-nitrophenyl palmitate as described in Materials and Methods. FA, fatty acid. Data represent means ± SD from three independent experiments. OA in the presence of radiolabeled glycerol to generate labeled glycerolipid pools. Cells were then washed and incubated for 2 h with or without E600 (100 µM). Cells were then incubated with or without E600 for 6 h. Cells and media were collected, and radioactivities in the various lipid classes were determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. *P < 0.005. 14 C]glycerol (pulse). Cells that were not treated with E600 were washed for 1 h in DMEM followed by a second wash with or without E600 (100 µM) and were subsequently incubated for 4 h with or without E600 (100 µM) (chase). Cells were collected, and radioactivities associated with the various lipids were determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. *P < 0.009. 14 C]glycerol (pulse). Cells that were not treated with E600 were washed for 1 h in DMEM followed by a second wash with or without E600 (100 µM) and were subsequently incubated for 4 h with or without E600 (100 µM) (chase). Media were collected, and radioactivities associated with the various lipids were determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. *P < 0.015; **P < 0.0001; ***P < 0.001; ****P < 0.005. Hepatocytes were incubated with 0.4 mM oleate to generate TG stores, were washed, and were then incubated 1 h with or without E600 (100 µM). Cells were subsequently incubated for 4 h with or without E600 (100 µM). Media and cells were collected, and TG contents were determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. *P < 0.05; **P < 0.002. Cellular TG levels were raised by incubation of the cells for 4 h with 0.4 mM OA. Cells were then incubated for 2 h with or without E600 (100 µM), followed by a 2-h incubation with radiolabeled leucine ± E600 ± lactacystin (10 µM). Cells and media were collected, apoB was immunoprecipitated, and radioactivity associated with the protein was determined after SDS-PAGE as described in Materials and Methods. A) Media apoB. B) Cellular apoB. Data represent means ± SD from three independent experiments. *P < 0.0001; **P < 0.02; ***P < 0.05. (white bars) specific inhibitor GR148672X. A) Hepatocytes were incubated with 0.4 mM oleate to generate TG stores, washed, and incubated for 1 h with or without GR148672X (10 µM). Cells were subsequently incubated for 4 h with or without GR148672X (10 µM). Media and cells were collected, and TG contents were determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. P < 0.02. B) Hepatocytes were treated as described above. Media apoB was collected by Cab-O-Sil precipitation and analyzed by immunoblotting as described in Materials and Methods. Results of densitometry analysis of the immunoblots are shown. 35 S-labeled methionine and cysteine with or without E600 (100 µM) or GR148672X (10 µM) (GSKi) as described in Materials and Methods. Cells were harvested in 2 ml of PBS containing protease inhibitors. The apoB was immunoprecipitated from 1-ml aliquots of cell sonicates and media. Samples were resolved via SDS-PAGE and transferred to nitrocellulose. The membranes were exposed to PhosphorImager screens, and resulting bands were quantitated by using Bio-Rad Quantity One software. Densitometry results of the PhosphorImager analysis are shown (means ± SD). B) Albumin secretion from primary rat hepatocytes. Hepatocytes were treated as in A, except that albumin was immunoprecipitated from 1-ml aliquots of media. Densitometry results of the PhosphorImager analysis are shown (means ± SD). C) LDH activity. Hepatocytes were incubated with 0.4 mM oleate to generate TG stores, washed, and incubated 1 h with or without 100 µM E600 or 10 µM GSKi. Cells were subsequently incubated for 4 h with or without 100 µM E600 or 10 µM GSKi. Some cells incubated without lipase inhibitors were incubated with DMEM for 3 h followed by DMEM containing 400 µM tert-butyl hydroperoxide (tBHP) for 1 h. Aliquots of medium were collected, and cells were scraped into 1 ml of PBS containing protease inhibitors. LDH activity was determined as described in Materials and Methods. Data represent means ± SD from three independent experiments. derived from cytosolic stores via a process that involves microsomal TG transfer protein (MTP). Lipolysis of the luminal droplet by TGH to partial acylglycerols such as diacylglycerol (DG) and fatty acids would provide substrates for TG resynthesis by luminally localized acyltransferases (diacylglycerol acyltransferse, DGAT) followed by TG loading onto nascent apoB-containing particles. TG that is not assembled into apoB may be returned to either cytosolic or luminal storage pools (futile cycle). Alternatively, TGH may access TGs that are released from the cytosolically oriented ERassociated lipid droplet. The released fatty acids and partial acylglycerols may be substrates for luminal TG synthesis.
